ArticleBMC pediatrics2026
Solitary extramedullary plasmacytoma of the kidney in a child: a case report.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSolitary extramedullary plasmacytoma (SEP) is a rare malignant neoplasm of plasma cells that predominantly affects adults, most commonly in the head and neck region. Renal involvement in children is exceedingly rare. We report a case of pediatric renal SEP to highlight its diagnostic challenges and management considerations. CASE PRESENTATION: A 10-year-old boy presented with intermittent painless gross hematuria. Computed tomography (CT) revealed a cystic-solid mass (4.8 × 4.7 × 4.5 cm) in the lower pole of the right kidney, initially suspected to be renal cell carcinoma. Right radical nephrectomy was performed, and histopathology confirmed plasmacytoma with kappa light chain restriction. Comprehensive evaluation excluded multiple myeloma (MM) and other extramedullary lesions. Notably, despite negative serum and urine protein electrophoresis, the serum free light chain (sFLC) ratio was abnormally elevated (κ/λ = 4.16), confirming monoclonality. A final diagnosis of renal SEP was established. No adjuvant therapy was administered. The patient remains disease-free at 26 months of follow-up, with sFLC ratio remaining within the normal range.
conclusionsPediatric renal SEP may mimic common malignant renal tumors, necessitating systematic pathological, hematological, bone marrow, and imaging assessments for accurate diagnosis. Complete surgical resection may be sufficient for localized lesions. sFLC analysis may serve as a valuable tool for diagnosis and monitoring. Long-term follow-up is essential given the risk of recurrence or progression to MM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.